Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.61 |
| ▸ | CA7 | P43166 | 3/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclamic Acid SCHEMBL11003910 | 1.00 | CA12 (0.61) | CA12CA7CA14CA1CA2 | |
| Cyclamic Acid SCHEMBL10999470 | 1.00 | CA12 (0.61) | CA12CA7CA14CA1CA2 | |
| Cyclamic Acid SCHEMBL29287057 | 0.98 | CA12 (0.58) | CA12CA7CA14CA1CA2 | |
| SCHEMBL1726858 | 0.97 | CA12 (0.64) | CA12CA7CA14CA1CA2 | |
| SCHEMBL1726879 | 0.97 | CA12 (0.64) | CA12CA7CA14CA1CA2 | |
| Cyclamic Acid SCHEMBL11686696 | 0.97 | CA12 (0.64) | CA12CA7CA14CA1CA2 | |
| Cyclamic Acid SCHEMBL6227 | 0.97 | CA12 (0.64) | CA12CA7CA14CA1CA2 | |
| SCHEMBL1727205 | 0.97 | CA12 (0.64) | CA12CA7CA14CA1CA2 | |
| SCHEMBL1727915 | 0.97 | CA12 (0.64) | CA12CA7CA14CA1CA2 | |
| Cyclamic Acid SCHEMBL18585752 | 0.97 | CA12 (0.64) | CA12CA7CA14CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 510 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250082623-A1 | COMPOSITIONS CONTAINING FEXOFENADINE | OPELLA HEALTHCARE GROUP SAS (FR) | 2025-03-13 | — | — | US | claimed |
| WO-2024264012-A1 | BIOAVAILABILITY ENHANCING IONIC LIQUID FORMULATIONS INCLUDING ANTHELMINITIC BENZIMIDAZOLE COMPOUNDS AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-12-26 | — | — | WO | claimed |
| WO-2024264013-A1 | BIOAVAILABILITY ENHANCING IONIC LIQUID FORMULATIONS AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-12-26 | — | — | WO | claimed |
| CN-117923831-B | Retarding water reducer | 山东同盛建材有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117923831-A | Retarding water reducer | 山东同盛建材有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2023126637-A1 | COMPOSITIONS CONTAINING FEXOFENADINE | OPELLA HEALTHCARE GROUP SAS (FR) | 2023-07-06 | — | — | WO | claimed |
| CN-110279636-A | A kind of whitening promoting and tooth-building toothpaste and preparation method thereof | 张衡 | 2019-09-27 | — | — | CN | claimed |
| CN-110123660-A | Peptides oral health toothpaste containing victory and preparation method thereof | 上海利盛生特企业发展有限公司 | 2019-08-16 | — | — | CN | claimed |
| CN-109715170-A | The composition and method for preventing or treating fatty pancreas, improve pancreopathy change caused by fatty pancreas, diabetes or other associated diseases | 财团法人国际教育基金会 | 2019-05-03 | — | — | CN | claimed |
| CN-109674719-A | Herbal mixture Caulis Spatholobi toothpaste and preparation method thereof | 夏祥华 | 2019-04-26 | — | — | CN | claimed |
| CN-1931138-A | Entecavir granule and its prepn process | HENAN FUREN PHARMACEUTICAL IND (CN) | 2007-03-21 | — | — | CN | claimed |
| CN-1302774-C | Efferverscent tablets containing troxerutin and their preparation | QIU XUELIANG (CN) | 2007-03-07 | — | — | CN | claimed |
| CN-1613444-A | Efferverscent tablets containing troxerutin and their preparation | QIU XUELIANG (CN) | 2005-05-11 | — | — | CN | claimed |
| CN-1476300-A | Calcium-added beverage and production method thereof | ���¿��ֹ�˾ | 2004-02-18 | — | — | CN | claimed |
| WO-2003082251-A2 | THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 α METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION | HEMOFARM KONCERN A.D. PHARMACEUTICAL AND CHEMICAL INDUSTRY (YU) | 2003-10-09 | — | — | WO | claimed |
| CN-1421206-A | Medical composition | GLAXO GROUP LTD (GB) | 2003-06-04 | — | — | CN | claimed |
| CN-1351488-A | Drinkable pharmaceutical suspensions | ETHYPHARM LAB PROD ETHIQUES (FR) | 2002-05-29 | — | — | CN | claimed |
| US-6083549-A | IMPROVING TASTE OF SWEETENERS OR FOODS | AJINOMOTO CO., INC. (JP) | 2000-07-04 | — | — | US | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| US-4680064-A | Phosphate conversion coating accelerators | GERHARD COLLARDIN GMBH (DE) | 1987-07-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250082623-A1 | COMPOSITIONS CONTAINING FEXOFENADINE | HRH2, IL5, HRH1 | CA12 94/4885CA7 520/4885CA14 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.